ImmuCell Corporation
ICCC
$9.89
-$0.02-0.17%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -55.30% | -100.70% | 51.78% | 160.98% | 143.51% |
| Total Depreciation and Amortization | -11.47% | -4.23% | 1.58% | 0.33% | -0.76% |
| Total Amortization of Deferred Charges | -9.26% | 8.33% | 27.70% | 47.97% | 8.54% |
| Total Other Non-Cash Items | 2,712.29% | 1,652.16% | 1,356.33% | -107.86% | -70.65% |
| Change in Net Operating Assets | 77.04% | 52.90% | -405.07% | -768.97% | -404.25% |
| Cash from Operations | 132.62% | 195.69% | 591.59% | 649.46% | 1,198.40% |
| Capital Expenditure | -118.14% | -51.66% | -168.52% | -263.28% | -12.59% |
| Sale of Property, Plant, and Equipment | -42.12% | 924.44% | 702.22% | 591.11% | 323.19% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -124.50% | -46.19% | -163.29% | -437.72% | -9.39% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -54.35% | -54.69% | -55.30% | -55.75% | 55.87% |
| Issuance of Common Stock | -96.40% | -92.93% | -92.49% | -78.47% | 949.45% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 92.51% | 88.20% | 72.20% | 62.61% | 22.44% |
| Cash from Financing | -147.55% | -142.47% | -142.05% | -127.72% | 270.93% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -38.78% | -39.18% | -98.26% | -95.74% | 3,695.46% |